Market Overview:
The global oral vaccines market is expected to grow at a CAGR of 9.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising demand for oral vaccines due to their ease of administration, and growing investments by key players in this market. Based on type, the global oral vaccines market is segmented into rotavirus vaccine, cholera vaccine, oral polio vaccine (OPV), and others. Rotavirus vaccine dominates this market owing to its high efficacy and widespread use across the globe. Cholera vaccine is expected to grow at a high rate during the forecast period as it offers protection against one of the deadliest diarrheal diseases caused by Vibrio cholerae bacteria. OPV is also anticipated to witness significant growth during the forecast period as it helps reduce polio cases around the world. Based on application, public sector dominates this market followed by private sector segments respectively owing higher adoption rates for these types of vaccines in developing countries such as India and China when compared with developed countries such as U.S., Canada or Europe).
Product Definition:
Oral vaccines are a type of vaccine that is given by mouth. Oral vaccines are usually made from a weakened or killed form of the virus, bacteria, or parasite that is being vaccinated against.
Rotavirus Vaccine:
Rotavirus is the leading cause of gastroenteritis in children. The disease has a high fatality rate and affects mostly infants and children below five years of age. According to WHO, about 250,000 deaths occur every year due to rotavirus infection globally with majority of them occurring in developing countries. In addition, it also reported that over 2 million cases are registered each year with majority of them being mild resulting in reduced hospitalization rates.
Cholera Vaccine:
Cholera vaccine is a subunit vaccine, which protects against cholera. It is recommended for people traveling to countries with a high risk of cholera and those working in or visiting places where there is a risk of exposure. The Centers for Disease Control and Prevention has identified the following countries as having an increased risk of contracting the disease: India, El Salvador, Guatemala, Mexico, Colombia (including Bogota), South America (excluding Brazil), Africa (excluding Egypt & S.
Application Insights:
On the basis of application, the global oral vaccines market is segmented into public and private. The public sector accounted for a larger share in 2017 owing to increasing prevalence of target diseases. For instance, according to WHO, rotavirus is highly prevalent among children below 5 years of age and accounts for about 60% of all diarrhea deaths worldwide every year. In addition, cholera also has high impact in terms of mortality and morbidity due to its rapid spread through contaminated water or food sources. Thus, these factors are anticipated to contribute towards growth in demand from the public sector over the forecast period.
The private sector includes both healthcare providers (hospitals & clinics) as well as households that have individuals affected with vaccine-preventable diseases such as rotavirus or cholera.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing government initiatives for immunization, rising awareness about vaccines, and availability of a wide range of vaccines. Moreover, high incidence rate of vaccine-preventable diseases is anticipated to boost demand for oral vaccines in this region. For instance, according to statistics published by CDC’s National Center for Immunization and Respiratory Diseases (NCIRD), around 3 million people were diagnosed with cancer every year from 2012 through 2016 associated with vaccination against HPV infection.
Asia Pacific is estimated to be the fastest-growing regional market over the forecast period due as increase in target population base along with growing awareness about immunization programs especially regarding oral vaccine formulations coupled with economic development & improvement in healthcare infrastructure & facilities which are expected over next eight years till 2030 time frame).
Growth Factors:
- Increasing incidence of infectious diseases: The global incidence of infectious diseases is increasing every year, which is expected to drive the demand for oral vaccines in the near future.
- Growing awareness about preventive measures: There is a growing awareness among people about the importance of preventive measures, including vaccination. This is likely to boost the demand for oral vaccines in the coming years.
- Technological advancements: Oral vaccine manufacturers are constantly investing in research and development activities to introduce new and innovative products in the market. This will help them gain a larger share of this growing market in the near future.
- Rising public-private partnerships: There has been an increase in public-private partnerships between vaccine manufacturers and governments across different countries worldwide over recent years, which will help promote growth of this market during forecast period . 5) Expanding distribution channels: Oral vaccine manufacturers are expanding their distribution channels to reach a wider customer base across different geographies
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Vaccines Market Research Report
By Type
Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine, Others
By Application
Public, Private
By Companies
Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Oral Vaccines Market Report Segments:
The global Oral Vaccines market is segmented on the basis of:
Types
Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Public, Private
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
Highlights of The Oral Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Others
- By Application:
- Public
- Private
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral vaccines are a type of vaccine that is taken by mouth. They are usually given as a series of shots over time.
Some of the key players operating in the oral vaccines market are Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals.
The oral vaccines market is expected to register a CAGR of 9.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oral Vaccines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oral Vaccines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oral Vaccines Market - Supply Chain
4.5. Global Oral Vaccines Market Forecast
4.5.1. Oral Vaccines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oral Vaccines Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oral Vaccines Market Absolute $ Opportunity
5. Global Oral Vaccines Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oral Vaccines Market Size and Volume Forecast by Type
5.3.1. Rotavirus Vaccine
5.3.2. Cholera Vaccine
5.3.3. Oral Polio Vaccine
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oral Vaccines Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oral Vaccines Market Size and Volume Forecast by Application
6.3.1. Public
6.3.2. Private
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oral Vaccines Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oral Vaccines Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oral Vaccines Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oral Vaccines Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oral Vaccines Demand Share Forecast, 2019-2026
9. North America Oral Vaccines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oral Vaccines Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oral Vaccines Market Size and Volume Forecast by Application
9.4.1. Public
9.4.2. Private
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oral Vaccines Market Size and Volume Forecast by Type
9.7.1. Rotavirus Vaccine
9.7.2. Cholera Vaccine
9.7.3. Oral Polio Vaccine
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oral Vaccines Demand Share Forecast, 2019-2026
10. Latin America Oral Vaccines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oral Vaccines Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oral Vaccines Market Size and Volume Forecast by Application
10.4.1. Public
10.4.2. Private
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oral Vaccines Market Size and Volume Forecast by Type
10.7.1. Rotavirus Vaccine
10.7.2. Cholera Vaccine
10.7.3. Oral Polio Vaccine
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oral Vaccines Demand Share Forecast, 2019-2026
11. Europe Oral Vaccines Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oral Vaccines Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oral Vaccines Market Size and Volume Forecast by Application
11.4.1. Public
11.4.2. Private
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oral Vaccines Market Size and Volume Forecast by Type
11.7.1. Rotavirus Vaccine
11.7.2. Cholera Vaccine
11.7.3. Oral Polio Vaccine
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential nalysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oral Vaccines Demand Share, 2019-2026
12. Asia Pacific Oral Vaccines Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oral Vaccines Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oral Vaccines Market Size and Volume Forecast by Application
12.4.1. Public
12.4.2. Private
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oral Vaccines Market Size and Volume Forecast by Type
12.7.1. Rotavirus Vaccine
12.7.2. Cholera Vaccine
12.7.3. Oral Polio Vaccine
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oral Vaccines Demand Share, 2019-2026
13. Middle East & Africa Oral Vaccines Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oral Vaccines Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oral Vaccines Market Size and Volume Forecast by Application
13.4.1. Public
13.4.2. Private
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oral Vaccines Market Size and Volume Forecast by Type
13.7.1. Rotavirus Vaccine
13.7.2. Cholera Vaccine
13.7.3. Oral Polio Vaccine
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oral Vaccines Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oral Vaccines Market: Market Share Analysis
14.2. Oral Vaccines Distributors and Customers
14.3. Oral Vaccines Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Merck
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. GSK
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sanofi
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Lanzhou Institute
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Serum Institute
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Valneva
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Shanghai United Cell
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bibcol
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. PaxVax
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Vabiotech
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Tiantan Biological
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. EuBiologics
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Panacea Biotec Ltd
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Bio-Med
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Halfkin Bio-Pharmaceuticals
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
